Rapid genotyping of MYD88 L265P and CD79B Y196 mutations is quite effective for intraoperative molecular diagnosis of PCNSL because it is sometimes difficult to distinguish PCNSL from inflammatory changes or other brain tumors. The gene discussed is MYD88; the disease is primary central nervous system lymphoma.